During a lull in the amount of product liability litigation in the country, two companies have the dubious honor of being the target of a growing number of lawsuits. Benicar maker Daiichi-Sankyo is one of them. According to statistics from the U.S. Judicial Panel on Multidistrict Litigation (JPML), the number of cases in recently-created MDLs for the Japanese-based drugmaker rose significantly between mid-April and mid-May of 2015.
A bit of interesting news has been flying under the radar involving a legal skirmish between Japanese drug maker Daiichi-Sankyo, manufacturer of the hypertension medication Benicar, and a couple of upstart companies that would like to produce and market their own generic versions. A federal judge's recent ruling on non-infringement of patent will allow Apotex, Inc. to enter the generic market earlier than it would have otherwise – but given the ongoing controversies over the drug, it's hard to know why it would want to.